We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+4.55%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$12.9B
AUM Growth
+$12.9B
Cap. Flow
+$2.44B
Cap. Flow %
18.95%
Top 10 Hldgs %
13.49%
Holding
489
New
192
Increased
92
Reduced
78
Closed
35

Top Sells

Rank Stock Value
1
HQY icon
HealthEquity
HQY
+$34.8M
2
RCL icon
Royal Caribbean
RCL
+$33.2M
3
OMCL icon
Omnicell
OMCL
+$29.2M
4
TYL icon
Tyler Technologies
TYL
+$29.1M
5
CGNX icon
Cognex
CGNX
+$28.3M

Sector Composition

Rank Sector Weight
1 Healthcare 18.54%
2 Technology 17.46%
3 Industrials 16.92%
4 Consumer Discretionary 15.93%
5 Financials 10.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEN icon
101
Penumbra
PEN
$12.6B
$40.5M 0.32%
361,292
IMPV
102
DELISTED
Imperva, Inc.
IMPV
$39.5M 0.31%
927,014
KEYS icon
103
Keysight
KEYS
$50.7B
$39.5M 0.31%
772,638
+121,045
+19% +$5.78M
NUVA
104
DELISTED
NuVasive, Inc.
NUVA
$39.2M 0.31%
739,039
MMSI icon
105
Merit Medical Systems
MMSI
$4.82B
$39.1M 0.3%
874,711
ILG
106
DELISTED
ILG, Inc Common Stock
ILG
$39.1M 0.3%
1,273,887
+317,622
+33% +$9.94M
INFO
107
DELISTED
IHS Markit Ltd. Common Shares
INFO
$38.5M 0.3%
811,137
+139,568
+21% +$6.6M
PUK icon
108
Prudential
PUK
$36.4B
$38.3M 0.3%
+394,611
New +$20M
SF
109
Stifel
SF
$12.4B
$38.1M 0.3%
1,491,305
-59,235
-4% -$1.68M
EG icon
110
Everest Group
EG
$15.6B
$37.5M 0.29%
+146,000
New +$35M
ADSK icon
111
Autodesk
ADSK
$51.8B
$37.3M 0.29%
303,811
+33,757
+13% +$4.02M
SXT icon
112
Sensient Technologies
SXT
$5.22B
$37.3M 0.29%
546,716
+25,000
+5% +$1.8M
XLRN
113
DELISTED
Acceleron Pharma
XLRN
$36.9M 0.29%
942,844
LITE icon
114
Lumentum
LITE
$46.9B
$36.6M 0.28%
594,857
NOW icon
115
ServiceNow
NOW
$120B
$36.3M 0.28%
1,123,915
+73,180
+7% +$2.26M
MCO icon
116
Moody's
MCO
$83.7B
$36.1M 0.28%
227,794
+28,141
+14% +$4.56M
TYL icon
117
Tyler Technologies
TYL
$13.7B
$36.1M 0.28%
176,531
-145,615
-45% -$29.1M
LGND icon
118
Ligand Pharmaceuticals
LGND
$5.77B
$35.9M 0.28%
359,748
AFAM
119
DELISTED
Almost Family Inc
AFAM
$35.9M 0.28%
+64,075
New +$3.69M
BC icon
120
Brunswick
BC
$5.23B
$35.7M 0.28%
623,727
+249,590
+67% +$14.8M
SRG
121
Seritage Growth Properties
SRG
$138M
$35.6M 0.28%
1,032,564
FNGN
122
DELISTED
Financial Engines, Inc.
FNGN
$35.6M 0.28%
+101,600
New +$3.19M
WAL icon
123
Western Alliance Bancorporation
WAL
$8.81B
$35.2M 0.27%
622,113
+96,998
+18% +$5.74M
THR
124
DELISTED
Thermon Group Holdings
THR
$35M 0.27%
1,591,313
+66,355
+4% +$1.53M
NVDA icon
125
NVIDIA
NVDA
$4.6T
$34.9M 0.27%
6,310,800
-2,284,800
-27% -$13.4M

Similar funds

Carillon Tower Advisers's Q1 2018 Portfolio in Review

As of Q1 2018, Carillon Tower Advisers held 489 positions worth $12.9B, up 136,756% from $9.4M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Carillon Tower Advisers deployed $2.44B of net new capital in Q1 2018, opening 192 new positions and adding to 92 existing holdings. Its largest new stake was Voya Financial: 871,250 shares worth $4.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was HealthEquity, an estimated $34.8M trimmed.

  • Carillon Tower Advisers's largest Q1 2018 buy was Voya Financial: 871,250 shares worth $4.4M.
  • Carillon Tower Advisers added most to DXC Technology in Q1 2018, an estimated $101M increase.
  • Carillon Tower Advisers's biggest Q1 2018 reduction was HealthEquity, cutting an estimated $34.8M.
  • Carillon Tower Advisers fully exited Prestige Consumer Healthcare in Q1 2018, selling an estimated $404K.
  • Carillon Tower Advisers's ten largest holdings make up 13% of its $12.9B portfolio in Q1 2018.
  • Carillon Tower Advisers opened 192 new positions and closed 35 in Q1 2018.
  • Carillon Tower Advisers's portfolio value rose 136,756% quarter-over-quarter to $12.9B.

Based on Carillon Tower Advisers's 13F filing for Q1 2018, filed 14 May 2018.